| NWHVX | PMAQX | NWHVX / PMAQX | |
| Total Expense Ratio | 1.10 | 0.57 | 193% |
| Annual Report Gross Expense Ratio | 1.10 | 0.57 | 193% |
| Fund Existence | 27 years | 10 years | - |
| Gain YTD | -4.860 | -7.830 | 62% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 260M | 23.8B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -16.49 | -14.13 | 117% |
| Returns for 3 years | -17.37 | 14.93 | -116% |
| Returns for 5 years | -60.36 | -1.11 | 5,429% |
| Returns for 10 years | -58.55 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSMIX | 33.68 | 0.26 | +0.78% |
| NYLI WMC Value Investor Class | |||
| VFSNX | 290.53 | N/A | N/A |
| Vanguard FTSE All-Wld ex-US SmCp Idx Ins | |||
| IVGTX | 9.95 | N/A | N/A |
| VY® Morgan Stanley Global Franchise S | |||
| EMFIX | 17.25 | N/A | N/A |
| Ashmore Emerging Markets Equity Instl | |||
| GAOTX | 21.22 | N/A | N/A |
| JPMorgan Global Allocation R3 | |||